In Conversation: SLAS Editors on Open Access

Update: 2021-10-27

Description

Join Jill Hronek, SLAS Director of Marketing and Communications, and Ally Jump, SLAS Publishing Manager, as they speak with SLAS Discovery and SLAS Technology’s respective Editors-in-Chief, Robert M. Campbell, Ph.D., (Twentyeight-Seven Therapeutics, Boston, MA USA) and Edward Kai-Hua Chow, Ph.D., (National University of Singapore, Singapore) about SLAS’s new Open Access model for the Society’s two peer-reviewed journals.

Beginning January 1, 2022 both SLAS Discovery and SLAS Technology will be available Open Access and through a new publisher, Elsevier. Tune in to have your questions answered about all things publishing and open access and hear what other exciting things the SLAS publishing team has in store for the new year.

Check out our SLAS Open Access FAQs and Elsevier Open Access Agreements to see if your institution covers publishing costs!

Comments

In Channel

Behind the Scenes at SLAS2023: Special Interview with Davide Gianni

2023-09-1308:32

Behind the Article: A Perspective on the Discovery of Enzyme Activators

2023-03-2909:45

New at SLAS: Protocols In Drug Discovery

2023-02-2212:57

Behind the Scenes at SLAS Europe: Special Interview with Jonathan Wingfield

2022-09-2112:25

Behind the Scenes at SLAS Europe: Special Interview with Timothy Spicer

2022-07-2015:21

Special Issue: 3D Cell Culture Approaches of Microphysiologically Relevant Models

2022-04-2715:31

SLAS Discovery x Assay Guidance Manual: Robust or Go Bust

2021-12-1519:32

Special Issue: Applications of Biophysics in Early Drug Discovery

2021-09-2214:03

Special Issue: Functional Genomics for Target Identification

2020-06-2313:14

Special Collection: Ion Channels and Relevant Drug Screening Approaches

2020-06-0106:21

Special Issue: Advances in Cellular Target Engagement and Target Deconvolution

2020-02-0121:59

Meet Editor-in-Chief Bob Campbell and SLAS Discovery!

2020-01-0111:08

In Conversation: SLAS Editors on Open Access

2021-10-2713:38

Approaches for Prioritizing High-Quality Chemical Matter in Chemical Probe and Drug Discovery

2021-08-1819:08

Special Issue: Advances in Protein Degradation

2021-06-3024:37

Selecting Approaches for Hit Identification and Increasing Options by Building the Efficient Discovery of Actionable Chemical Matter from DNA-Encoded Libraries

2021-01-1332:31

High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2

2020-11-1811:22

Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response

2020-07-2307:53